Promising ‘Liquid Biopsies’ May Not Be Ready for Primetime (opens in new tab)
Joshua Cohen in Undark Magazine: An emerging technology seeks to help revolutionize the world of cancer diagnosis: Multi-cancer early detection tests aim to spot signals for different types of cancer from a single blood draw or other body fluid sample. Also known as a specific type of liquid biopsy, MCED tests look for abnormalities that may indicate cancer, like circulating…
Read the original article